Dr. Ranmal Aloka Samarasinghe, MD, PhD

Dr. Samarasinghe practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Samarasinghe's NPI, 1588906606, was assigned on March 27, 2013. Dr. Samarasinghe graduated from University of Pittsburgh School of Medicine in 2012. Dr. Samarasinghe holds California license A133639.

Dr. Samarasinghe's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Samarasinghe's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Samarasinghe is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Health. Dmand AI also links Dr. Samarasinghe to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samarasinghe practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Samarasinghe's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Samarasinghe is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Samarasinghe's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 1,548 Medicare services from Dr. Samarasinghe across 5 procedure codes in 2024, for 85 Medicare patients. Medicare paid $47,005 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Samarasinghe in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samarasinghe's median patient age at 53, with 52% women.

In 2021, Dr. Samarasinghe wrote 37 Medicare Part D claims. They cover 2 drugs, with $14,702 in total drug cost. In 2020, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Samarasinghe for performance year 2024, reported as part of a group. Dr. Samarasinghe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Samarasinghe, published from 2011 to 2024. 2011 was the busiest year, with 2. Dr. Samarasinghe's most frequent co-authors are Jack J. Lin, MD and Jack Mordecai Parent, MD.

CMS Open Payments shows 8 general payments to Dr. Samarasinghe from 3 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $219.

Dr. Samarasinghe graduated from University of Pittsburgh School of Medicine in 2012.

Dr. Samarasinghe is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.